Skip to content

Clinical trials

Terminated Phase 1 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Status: Terminated Country / region: Hong Kong Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20162
20171
20182
20193
20203
20214
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Hoffmann-La Roche3
Merck Sharp & Dohme LLC2
Aligos Therapeutics1
Alnylam Pharmaceuticals1
Arbutus Biopharma Corporation1
New Beta Innovation Limited1
Pyramid Biosciences1
Viracta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Hepatitis B2
Lymphoma, Large B-Cell, Diffuse2
Neoplasms2
Brain Neoplasms1
Desmoplastic Small Round Cell Tumor1
Esophageal Squamous Cell Carcinoma1
Gastrointestinal Stromal Tumors1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.